Department of Defense: Kidney Cancer Research Program (KCRP) FY17

The Fiscal Year 2017 (FY17) Kidney Cancer Research Program (KCRP) is currently accepting applications for four award mechanisms:

Consortium Development Award

The Consortium Development Award is a clinical trial infrastructure mechanism that provides support to create a Coordinating Center and to establish the necessary collaborations at potential Clinical Trial Sites for the development of a multi-institutional kidney clinical effort relevant to active duty Service members, Veterans, other military beneficiaries, and the American public.

  • Maximum funding of US $1M (approx. AUD $1.3M) for a maximum period of 2 years.
  • Principal Investigator’s (PIs) and Co-PIs that are faculty members at or above Assistant Professor (or equivalent) level are eligible.

Idea Development Award

The Idea Development Award is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the KCRP vision of eliminating kidney cancer. The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach.

  • Maximum funding of US $400,000 (approx. AUD $521,000) for a maximum period of 3 years.
  • Established Investigators or Early Career Investigators are eligible.

Concept Award

The Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in kidney cancer. This award is not intended to support an incremental progression of an already established research project but, instead, allows PIs the opportunity to pursue serendipitous observations.

  • Maximum funding of US $75,000 (approx. AUD $97,700) for a maximum period of 1 year.
  • All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible.

Translational Research Partnership Award

This award supports the development of translational research collaborations between two independent, faculty level (or equivalent) investigators to address a central problem or question in kidney cancer in a manner that would be less readily achievable through separate efforts. One partner in the collaboration must be a research scientist and the other must be a clinician.

  • Maximum funding of US $600,000 (approx. AUD $781,500) for a maximum period of 3 years.
  • The Initiating PI and Partnering PI must be at or above the level of Assistant Professor (or equivalent).


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Dates

Further Information

Need Help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding and tagged . Bookmark the permalink.

Comments are closed.